A. Turnbull

发表

Novel histopathologic feature identified through image analysis augments stage II colorectal cancer clinical reporting

P. Caie, Ying Zhou, A. Turnbull, 2016, Oncotarget.

Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel Biomarkers

A. Turnbull, D. Harrison, Romina Briffa, 2015, PloS one.

HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer

C. Ward, A. Turnbull, S. Langdon, 2019, Breast Cancer Research.

Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast.

A. Turnbull, Jeremy S. Thomas, J. Dixon, 2017, Cancer treatment reviews.

The Importance of the Tumor Microenvironment and Hypoxia in Delivering a Precision Medicine Approach to Veterinary Oncology

A. Turnbull, L. Pang, D. Argyle, 2020, Frontiers in Veterinary Science.

Clinical biomarkers of response to neoadjuvant endocrine therapy in breast cancer: exploring the potential of gene expression data integration

A. Turnbull, 2013 .

Quantification of tumour budding, lymphatic vessel density and invasion through image analysis in colorectal cancer

P. Caie, A. Turnbull, A. Oniscu, 2014, Journal of Translational Medicine.

MolecularChanges inLobularBreastCancers inResponse to Endocrine Therapy

A. Turnbull, Jeremy S. Thomas, J. Dixon, 2014 .

Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer

A. Turnbull, J. Fraser, L. Pang, 2020, Frontiers in Oncology.

Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors

A. Hill, L. Hudson, A. Turnbull, 2016, Clinical Cancer Research.

Changes in PIK3CA mutation status are not associated with recurrence, metastatic disease or progression in endocrine-treated breast cancer

T. Wilson, J. Dixon, A. Turnbull, 2014, Breast Cancer Research and Treatment.

Current trends in the treatment of HR+/HER2+ breast cancer.

A. Turnbull, J. Dixon, C. Kay, 2021, Future oncology.

Stromal Transcriptome Analysis of Human Lobular Breast Cancer Identifies a Role for Pregnancy-Associated-Plasma Protein-A

C. Oxvig, A. Turnbull, N. Bertos, 2020 .

Explorer Comparative Analysis of the Development of Acquired Radioresistance in Canine and Human Mammary Cancer Cell Lines

A. Turnbull, L. Pang, D. Argyle, 2020 .

Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic

M. Ellis, M. Dowsett, J. Robertson, 2020, npj Breast Cancer.

Edinburgh Research Explorer HER2 regulates HIF-2 and drives an increased hypoxic response in breast cancer

C. Ward, A. Turnbull, S. Langdon, 2019 .

Primary acinic cell carcinoma of the breast is associated with a poor outcome: A case report and literature review

A. Turnbull, O. Oikonomidou, A. Diana, 2021, Molecular and clinical oncology.

Construction of a large scale integrated map of macrophage pathogen recognition and effector systems

Ying Chen, Tom C. Freeman, Peter Ghazal, 2010, BMC Systems Biology.

Integrated DNA and RNA Sequencing Reveals Drivers of Endocrine Resistance in Estrogen Receptor–Positive Breast Cancer

C. Perou, Xiaping He, J. Parker, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

A Novel Approach for the Discovery of Biomarkers of Radiotherapy Response in Breast Cancer

A. Turnbull, I. Kunkler, J. Dixon, 2021, Journal of personalized medicine.

Diagnostics of Ovarian Tumors in Postmenopausal Patients

A. Turnbull, S. Vesnin, A. Goltsov, 2022, Diagnostics.

Molecular changes in lobular breast cancers in response to endocrine therapy.

A. Turnbull, J. Dixon, C. Kay, 2014, Cancer research.

Predictive markers of endocrine response in breast cancer

C. Ward, A. Turnbull, S. Langdon, 2018, World journal of experimental medicine.

The evolving role of receptors as predictive biomarkers for metastatic breast cancer

A. Turnbull, J. Dixon, C. Martínez-Pérez, 2018, Expert review of anticancer therapy.

Tissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine

A. Turnbull, D. McLaren, C. Kay, 2021, Journal of personalized medicine.

Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment

C. Ward, A. Turnbull, S. Langdon, 2018, BMC Cancer.

Development and characterisation of acquired radioresistant breast cancer cell lines

C. Ward, A. Turnbull, L. Pang, 2019, Radiation Oncology.

Molecular changes during extended neoadjuvant letrozole treatment of breast cancer: distinguishing acquired resistance from dormant tumours

A. Turnbull, J. Dixon, A. Sims, 2018, Breast Cancer Research.

Comparative Analysis of the Development of Acquired Radioresistance in Canine and Human Mammary Cancer Cell Lines

A. Turnbull, L. Pang, D. Argyle, 2020, Frontiers in Veterinary Science.

Naturally-Occurring Canine Mammary Tumors as a Translational Model for Human Breast Cancer

A. Turnbull, L. Pang, D. Argyle, 2020, Frontiers in Oncology.

The IL6-like Cytokine Family: Role and Biomarker Potential in Breast Cancer

A. Turnbull, J. Dixon, C. Kay, 2021, Journal of Personalized Medicine.

Tumour sampling method can significantly influence gene expression profiles derived from neoadjuvant window studies

J. Bartlett, A. Turnbull, J. Dixon, 2016, Scientific Reports.

Passive Microwave Radiometry and microRNA Detection for Breast Cancer Diagnostics

A. Turnbull, S. Vesnin, A. Goltsov, 2022, Diagnostics.

Characterisation of the Stromal Microenvironment in Lobular Breast Cancer

C. Oxvig, R. Natrajan, A. Turnbull, 2022, Cancers.

Identification of stromal genes differentially expressed in lobular breast cancer highlights role for pregnancy-associated-plasma protein-A

C. Oxvig, A. Turnbull, N. Bertos, 2020, bioRxiv.

Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: comparison of gene expression profiling approaches

Charles M. Perou, Carlos Martinez-Perez, Richard Clark, 2020, BMC Bioinformatics.

Direct integration of intensity-level data from Affymetrix and Illumina microarrays improves statistical power for robust reanalysis

R. Kitchen, A. Turnbull, A. Larionov, 2012, BMC Medical Genomics.

Neoadjuvant endocrine therapy in postmenopausal women with HR+/HER2- breast cancer

J. Dixon, A. Turnbull, C. Kay, 2023, Expert review of anticancer therapy.

Preoperative Endocrine Therapy

A. Turnbull, J. Dixon, Laura M. Arthur, 2020 .

Pre-operative Endocrine Therapy

A. Turnbull, J. Dixon, Laura M. Arthur, 2017, Current Breast Cancer Reports.

The Signal Transducer IL6ST (gp130) as a Predictive and Prognostic Biomarker in Breast Cancer

A. Turnbull, J. Dixon, C. Kay, 2021, Journal of personalized medicine.

A PAM50-Based Chemoendocrine Score for Hormone Receptor–Positive Breast Cancer with an Intermediate Risk of Relapse

C. Perou, M. Dowsett, J. Parker, 2016, Clinical Cancer Research.

Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer.

M. Dowsett, A. Turnbull, J. Dixon, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic

M. Ellis, M. Dowsett, J. Robertson, 2020, npj Breast Cancer.

Personalized medicine in cancer: where are we today?

A. Turnbull, 2015, Future oncology.

Priority Report MolecularChanges inLobularBreastCancers inResponse to Endocrine Therapy

A. Turnbull, J. Dixon, C. Kay, 2014 .

HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer

C. Ward, A. Turnbull, S. Langdon, 2019, Breast Cancer Research.

Estrogen Receptor Pathway Activity Score to Predict Clinical Response or Resistance to Neoadjuvant Endocrine Therapy in Primary Breast Cancer

J. Martens, P. Kuppen, C. V. D. van de Velde, 2019, Molecular Cancer Therapeutics.

Antitumour activity of the novel flavonoid Oncamex in preclinical breast cancer models

C. Ward, A. Turnbull, D. Harrison, 2016, British Journal of Cancer.

Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells

C. Supuran, C. Ward, A. Turnbull, 2017, Oncotarget.

Oncotarget paper published

C. Supuran, C. Ward, A. Turnbull, 2017 .

Explorer Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells

C. Supuran, C. Ward, A. Turnbull, 2017 .

A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models

C. Ward, A. Turnbull, S. Langdon, 2015, Oncotarget.

Risk of chemotherapy-related amenorrhoea (CRA) in premenopausal women undergoing chemotherapy for early stage breast cancer

A. Turnbull, C. Martínez-Pérez, A. Rigg, 2020, Breast Cancer Research and Treatment.

On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer

D. Cameron, A. Turnbull, A. Sims, 2019, Breast Cancer Research.

Accurate Estrogen Receptor Quantification in Patients with Negative and Low-Positive Estrogen-Receptor-Expressing Breast Tumors: Sub-Analyses of Data from Two Clinical Studies

Baljit Singh, F. Baehner, D. Cameron, 2019, Advances in Therapy.

Comparison of long-term outcomes of breast conservation and reconstruction after mastectomy using BREAST-Q.

A. Turnbull, M. Schaverien, M. Mensa, 2022, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: comparison of gene expression profiling approaches

C. Perou, Xiaping He, L. Carey, 2020, BMC Bioinformatics.

Abstract P3-11-13: On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer

D. Cameron, A. Turnbull, A. Sims, 2019, Poster Session Abstracts.

HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer

C. Ward, A. Turnbull, S. Langdon, 2019, Breast Cancer Research.

The Efficacy of Sunitinib Treatment of Renal Cancer Cells Is Associated with the Protein PHAX In Vitro

A. Reverter, A. Turnbull, D. Harrison, 2020, Biology.

Variation in IL6ST cytokine family function and the potential of IL6 trans-signalling in ERα positive breast cancer cells.

A. Turnbull, S. Langdon, K. Macleod, 2022, Cellular signalling.

CCR-21-3189 3618..3629

C. Perou, Xiaping He, J. Parker, 2022 .

Mondor's disease of the breast: A cutaneous thromboembolic manifestation of Covid-19?

A. Turnbull, J. Dixon, L. Renshaw, 2022, The Breast.

A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models

C. Ward, A. Turnbull, S. Langdon, 2015 .

Oncotarget paper published

C. Supuran, C. Ward, A. Turnbull, 2017 .

On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer

D. Cameron, A. Turnbull, A. Sims, 2019, Breast Cancer Research.

Factors affecting the number of sentinel lymph nodes removed in patients having surgery for breast cancer

A. Turnbull, D. Twelves, C. Martínez-Pérez, 2020, Breast Cancer Research and Treatment.

The importance of the tumour microenvironment and hypoxia in delivering a precision medicine approach to veterinary oncology

A. Turnbull, L. Pang, D. Argyle, 2020 .

The Role of Nodes and Nodal Assessment in Diagnosis, Treatment and Prediction in ER+, Node-Positive Breast Cancer

A. Turnbull, C. Kay, C. Martínez-Pérez, 2023, Journal of personalized medicine.

Quantification of tumour budding, lymphatic vessel density and invasion through image analysis in colorectal cancer

P. Caie, A. Turnbull, A. Oniscu, 2014, Journal of Translational Medicine.

Diagnostic accuracy of core biopsy in patients presenting with axillary lymphadenopathy and suspected non-breast malignancy.

A. Turnbull, D. Twelves, W. Jack, 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.